|First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children|
RTS, S Clinical Trials Partnership
New England Journal of Medicine 365 (20), 1863-1875, 2011
|Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …|
The Lancet 386 (9988), 31-45, 2015
|Phase 1 trials of rVSV Ebola vaccine in Africa and Europe|
ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ...
New England Journal of Medicine 374 (17), 1647-1660, 2016
|A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants|
RTS, S Clinical Trials Partnership
New England Journal of Medicine 367 (24), 2284-2295, 2012
|Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine|
DE Neafsey, M Juraska, T Bedford, D Benkeser, C Valim, A Griggs, ...
New England Journal of Medicine 373 (21), 2025-2037, 2015
|The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial|
A Huttner, JA Dayer, S Yerly, C Combescure, F Auderset, J Desmeules, ...
The Lancet Infectious diseases 15 (10), 1156-1166, 2015
|Placental malaria increases malaria risk in the first 30 months of life|
NG Schwarz, AA Adegnika, LP Breitling, J Gabor, ST Agnandji, ...
Clinical Infectious Diseases 47 (8), 1017-1025, 2008
|Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites|
RTS, S Clinical Trials Partnership (2014)
PLoS medicine 11 (7), e1001685, 2014
|Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial|
MT White, R Verity, JT Griffin, KP Asante, S Owusu-Agyei, B Greenwood, ...
The Lancet infectious diseases 15 (12), 1450-1458, 2015
|Microscopic and sub-microscopic Plasmodium falciparum infection, but not inflammation caused by infection, is associated with low birth weight|
AA Adegnika, JJ Verweij, ST Agnandji, SK Chai, LP Breitling, ...
The American journal of tropical medicine and hygiene 75 (5), 798-803, 2006
|Safety and efficacy of the RTS, S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase …|
KP Asante, S Abdulla, S Agnandji, J Lyimo, J Vekemans, ...
The Lancet infectious diseases 11 (10), 741-749, 2011
|Intermittent preventive treatment against malaria in infants in Gabon-a randomized, double-blind, placebo-controlled trial|
MP Grobusch, B Lell, NG Schwarz, J Gabor, J Dörnemann, M Pötschke, ...
The Journal of infectious diseases 196 (11), 1595-1602, 2007
|Efficacy of RTS, S malaria vaccines: individual-participant pooled analysis of phase 2 data|
P Bejon, MT White, A Olotu, K Bojang, JPA Lusingu, N Salim, NN Otsyula, ...
The Lancet infectious diseases 13 (4), 319-327, 2013
|A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS, S malaria vaccine candidates in children in Gabon|
B Lell, S Agnandji, I Von Glasenapp, S Haertle, S Oyakhiromen, S Issifou, ...
PLoS one 4 (10), 2009
|Epidemiology of parasitic co‐infections during pregnancy in Lambaréné, Gabon|
AA Adegnika, M Ramharter, ST Agnandji, U Ateba Ngoa, S Issifou, ...
Tropical Medicine & International Health 15 (10), 1204-1209, 2010
|Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon|
M Ramharter, K Schuster, MK Bouyou-Akotet, AA Adegnika, K Schmits, ...
The American journal of tropical medicine and hygiene 77 (3), 418-422, 2007
|Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa|
A Leach, J Vekemans, M Lievens, O Ofori-Anyinam, C Cahill, ...
Malaria journal 10 (1), 224, 2011
|Evaluation of the Safety and Immunogenicity of the RTS,S/AS01E Malaria Candidate Vaccine When Integrated in the Expanded Program of Immunization|
ST Agnandji, KP Asante, J Lyimo, J Vekemans, SS Soulanoudjingar, ...
The Journal of infectious diseases 202 (7), 1076-1087, 2010
|History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon|
M Ramharter, AA Adegnika, ST Agnandji, PB Matsiegui, MP Grobusch, ...
Wiener klinische Wochenschrift 119 (3), 8-12, 2007
|Cortisol and susceptibility to malaria during pregnancy|
MK Bouyou-Akotet, AA Adegnika, ST Agnandji, E Ngou-Milama, ...
Microbes and Infection 7 (11-12), 1217-1223, 2005